A case study presented at Child Neurology Society Annual Meeting demonstrates preservation of neurological function in ...

(Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third ...

Callio leaders delivered three presentations and two panel discussions on dual-payload ADC resistance, manufacturability, ...

The event will feature John Affeldt, MD, from Loma Linda University Health, a leading expert in limbal stem cell deficiency ...

Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital ...

SAN DIEGO, CA / ACCESS Newswire / October 15, 2026 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata," or the "Company"), ...

While Oppenheimer doesn’t see the Phase 3 stumble of VQW-765 as highly detrimental to Vanda Pharmaceuticals, the analyst ...

On the same day, Alligator will host a webinar and conference call for investors, analysts and media at 2:00 p.m. CEST / 8:00 ...

Hospitals that have ordered Symvess® increased 44% during the third quarter, from 34 at the end of the second quarter to 49 ...

In advance of November 10, 2026, GDUFA goal date, all requested changes were classified as “MINOR.” NRx was requested to ...

In this episode of Denatured, presented by Cytiva, Jennifer Smith-Parker speaks to Nicolas Pivet, VP & GM, Manufacturing & ...

SAN DIEGO, Oct. 14, 2026 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical-stage biotech company focused on ...